ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

DCBD Board Votes down, Then Approves Organ Systems PA

November 10, 1989

In Brief: Proposed Drug Act Revisions Would Provide Quick Approval Of “Breakthroughs,” IND_NDA Changes

March 24, 1978

Fellowships In Japan Available Through NIH

October 13, 1995

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

NIH Offers Grant Funds for Support of Minority, Disabled Researchers

February 16, 1996

In Brief: President Asks $700 Million for NCI In 1977; Appropriation Delay Halts New Research Funds

January 2, 1976